| Latest List of Publications |
1- El-Feky Y.A., Fares A.R., Zayed G., Ahmed K.A., El-Telbany D.F.A. Repurposing of nifedipine loaded in situ ophthalmic gel as a novel approach for glaucoma treatment. Biomedicine and Pharmacotherapy, 2021, 142, 112008. DOI: 10.1016/j.biopha.2021.112008.
2- Nasr N.E.H., Metwaly M.G., Ahmed, E.O., Fares A.R., ElMeshad A.N. Investigating the root cause of N-nitrosodimethylamine formation in metformin pharmaceutical products. Expert Opinion on Drug Safety, 2021, 20(7), pp. 855–862. DOI: 10.1080/14740338.2021.1917547.
3- Haider M., Elsayed I., Ahmed I.S., Fares A.R. In situ-forming microparticles for controlled release of rivastigmine: In vitro optimization and in vivo evaluation. Pharmaceuticals, 2021, 14(1), pp. 1–21, 66. DOI: 10.3390/ph14010066.
4- Delan W.K., Zakaria M., Elsaadany B., Mamdouh W., Fares A.R. Formulation of simvastatin chitosan nanoparticles for controlled delivery in bone regeneration: Optimization using Box-Behnken design, stability and in vivo study. International Journal of Pharmaceutics, 2020, 577, 119038. DOI: 10.1016/j.ijpharm.2020.119038.
5- Elsenosy F.M., Abdelbary G.A., Elshafeey A.H., Elsayed I., Fares A.R, Brain targeting of duloxetine hcl via intranasal delivery of loaded cubosomal gel: In vitro characterization, ex vivo permeation, and in vivo biodistribution studies. International Journal of Nanomedicine, 2020, 15, pp. 9517–9537. DOI: 10.2147/IJN.S277352.
6- Al-Mahallawi AM, Fares AR, Abd-Elsalam WH. “Enhanced Permeation of Methotrexate via Loading into Ultra-permeable Niosomal Vesicles: Fabrication, Statistical Optimization, Ex Vivo Studies, and In Vivo Skin Deposition and Tolerability”. AAPS PharmSciTech 2019; 20(5):171, DOI: 10.1208/s12249-019-1380-5.
7- Ahmed MA, Saweeres ES, Abdelkader NA, Abdelmajeed SF, Fares AR. “Improved Pain and Function in Knee Osteoarthritis with Dexamethasone Phonophoresis: A Randomized Controlled Trial”. Indian J Orthop. 2019; 53(6):700 – 707, DOI: 10.4103/ortho.IJOrtho_639_18.
8- Fares AR, ElMeshad AN, Kassem MA. “Enhancement of dissolution and oral bioavailability of lacidipine via Pluronic P123/F127 mixed polymeric micelles: formulation, optimization using central composite design and in-vivo bioavailability study”. Drug Delivery 2018; 25(1):132 – 142, DOI: 10.1080/10717544.2017.1419512.
9- Kassem MA, ElMeshad AN, Fares AR. Enhanced Solubility and Dissolution Rate of Lacidipine Nanosuspension: Formulation via Antisolvent Sonoprecipitation Technique and Optimization Using Box-Behnken Design. AAPS PharmSciTech 2016; 18(4):983 – 996, DOI: 10.1208/s12249-016-0604-1.
10- Kassem MA, ElMeshad AN, Fares AR. “Lyophilized sustained release mucoadhesive chitosan sponges for buccal buspirone hydrochloride delivery: formulation and in vitro evaluation”. AAPS PharmSciTech 2015; 16(3):537 – 47, DOI: 10.1208/s12249-014-0243-3.
11- Kassem MA, ElMeshad AN, Fares AR. Enhanced bioavailability of buspirone hydrochloride via cup and core buccal tablets: Formulation and in vitro/in vivo evaluation. Int J Pharm 2014; 463(1):68 – 80, DOI: 10.1016/j.ijpharm.2014.01.003. |